Spinal Cord Injury Management Based on Microglia-Targeting Therapies
Journal of Clinical Medicine · 08.05.2024 · 13 (10) · 2773
DOI: 10.3390/jcm13102773 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.05.2024. Verfasst von Thomas Gabriel Schreiner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Specialties III, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Spinal cord injury is a complicated medical condition both from the clinician’s point of view in terms of management and from the patient’s perspective in terms of unsatisfactory recovery. Depending on the severity, this disorder can be devastating despite the rapid and appropriate use of modern imaging techniques and convenient surgical spinal cord decompression and stabilization. In this context, there is a mandatory need for novel adjunctive therapeutic approaches to classical treatments to improve rehabilitation chances and clinical outcomes. This review offers a new and original perspective on therapies targeting the microglia, one of the most relevant immune cells implicated in spinal cord disorders. The first part of the manuscript reviews the anatomical and pathophysiological importance of the blood-spinal cord barrier components, including the role of microglia in post-acute neuroinflammation. Subsequently, the authors present the emerging therapies based on microglia modulation, such as cytokines modulators, stem cell, microRNA, and nanoparticle-based treatments that could positively impact spinal cord injury management. Finally, future perspectives and challenges are also highlighted based on the ongoing clinical trials related to medications targeting microglia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Specialties III, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
- First Neurology Clinic, "Prof. Dr. N. Oblu" Clinical Emergency Hospital, 700309 Iasi, Romania.
- Department of Electrical Measurements and Materials, Faculty of Electrical Engineering and Information Technology, Gheorghe Asachi Technical University of Iasi, 700050 Iasi, Romania.
- Medical Oncology Department, Regional Institute of Oncology, 700483 Iasi, Romania.
ORCID-Profile: Thomas Gabriel Schreiner
Zitieren
APA
Schreiner, T. G., Schreiner, O. D., & Ciobanu, R. C. (2024). Spinal Cord Injury Management Based on Microglia-Targeting Therapies. Journal of Clinical Medicine, 13(10), 2773. https://doi.org/10.3390/jcm13102773
Vancouver
Schreiner TG, Schreiner OD, Ciobanu RC. Spinal Cord Injury Management Based on Microglia-Targeting Therapies. Journal of Clinical Medicine. 2024;13(10):2773. doi:10.3390/jcm13102773
BibTeX
@article{Schreiner2024,
author = {Schreiner, Thomas Gabriel and Schreiner, Oliver Daniel and Ciobanu, Romeo Cristian},
title = {Spinal Cord Injury Management Based on Microglia-Targeting Therapies},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {10},
pages = {2773},
doi = {10.3390/jcm13102773}
}
EUVIMED